Phaseline

Targets › IL7RA

IL7RA: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Oncology.

Open in Phaseline: the race on IL7RA, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Chulalongkorn UniversityB7H3 specific CAR T cell with IL-7Ra signaling domain
Anti-B7H3 CAR-T cell therapy with IL-7 receptor alpha co-stimulatory signaling domain
B7H3, IL7RAPhase 1DIPG Brain Tumor–

Conditions

DIPG Brain Tumor (1)

Modalities

other (1)

Companies

Chulalongkorn University (1)

Related targets

B7H3 (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.